1. LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer. (23rd October 2018) Authors: Ko, A H; Cubillo, A; Kundranda, M; Zafar, S F; Meiri, E; Bendell, J; Alguel, H; Rivera Herrero, F; Ahn, E; Watkins, D; Pelzer, U; Charu, V; Downing, W; Wang, B; Kuesters, G; Pipas, J M; Santillana, S L; Askoxylakis, V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 19 Reducing the match day injury rate at a semi-professional rugby club: an audit of injury between 2013 and 2015. (13th October 2015) Authors: Smith, R; Downing, W; Thompson, D; Fitch, S; Bowler, S Journal: British journal of sports medicine Issue: Volume 49(2015)Supplement 2 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗